FDA likely to approve new COVID-19 booster targeting latest variants
A new bivalent booster that experts say will protect against the two most dominant COVID-19 variants is expected to be approved by the Food and Drug Administration. The new booster arrives as the country experiences a mini-wave of the illness as well as a bump in hospitalizations and deaths.
Epidemiologist Abdul El-Sayed joins host Robin Young to discuss the significance of the shot.
This article was originally published on WBUR.org.
Copyright 2023 NPR. To see more, visit https://www.npr.org.